Structure |
Chemical Name |
CAS |
MF |
![Linagliptin Impurity 28](/CAS/20210305/GIF/2074688-84-7.gif) |
Linagliptin Impurity 28 |
2074688-84-7 |
C22H23N7O3 |
![Pantoprazole Impurity 3](/) |
Pantoprazole Impurity 3 |
|
|
![Ticagrelor Related Compound 58](/) |
Ticagrelor Related Compound 58 |
|
|
![Vildagliptin Impurity 9](/) |
Vildagliptin Impurity 9 |
|
|
![Cefathiamidine Impurity 5](/CAS/20210111/GIF/40818-86-8.gif) |
Cefathiamidine Impurity 5 |
40818-86-8 |
C10H11ClN2O4S |
![methyl 4-hydroxy-3,5-diisopropylbenzoic acid](/CAS/20200401/GIF/CB94632404.gif) |
methyl 4-hydroxy-3,5-diisopropylbenzoic acid |
|
C14H20O3 |
![Brexpiprazole Impurity M](/) |
Brexpiprazole Impurity M |
|
|
![Cefaclor Impurity 5](/) |
Cefaclor Impurity 5 |
|
|
![Linagliptin Impurity 39](/) |
Linagliptin Impurity 39 |
|
|
![Peramivir Impurity 5](/) |
Peramivir Impurity 5 |
|
|
![Pidotimod Impurity O](/) |
Pidotimod Impurity O |
|
|
![Pramipexole EP Impurity C](/) |
Pramipexole EP Impurity C |
|
|
![Imiquimod Impurity 5](/CAS/20210111/GIF/853793-02-9.gif) |
Imiquimod Impurity 5 |
853793-02-9 |
C15H18N4 |
![9-(1,3-diacetate-2-propoxymethyl)guanine](/CAS/20200401/GIF/86357-19-9.gif) |
9-(1,3-diacetate-2-propoxymethyl)guanine |
86357-19-9 |
C13H17N5O6 |
![Cefadroxil Impurity 6](/CAS/20210111/GIF/2378158-45-1.gif) |
Cefadroxil Impurity 6 |
2378158-45-1 |
C32H32N6O9S2 |
![Loratadine Impurity 9](/CAS/20200401/GIF/CB94657612.gif) |
Loratadine Impurity 9 |
125743-81-9 |
C22H23ClN2O2 |
![Metronidazole Impurity 1](/) |
Metronidazole Impurity 1 |
|
|
![Parecoxib Impurity 16](/CAS/20210111/GIF/2235371-89-6.gif) |
Parecoxib Impurity 16 |
2235371-89-6 |
C19H18N2O4S |
![Rosuvastatin Impurity 54](/) |
Rosuvastatin Impurity 54 |
|
|
![Vonoprazan Fumarate Impurity 6](/CAS/20210111/GIF/2250243-23-1.gif) |
Vonoprazan Fumarate Impurity 6 |
2250243-23-1 |
C33H27F2N5O4S2 |
![3-((3aS,4R,6S,6aR)-6-(2-hydroxyethoxy)-2,2-dimethyltetrahydro- 4H-cyclopenta[d][1,3]dioxol-4-yl)-5-(propylthio)-3H-[1,2,3] triazolo[4,5-d]pyrimidin-7-ol](/CAS/20200401/GIF/1456538-51-4.gif) |
3-((3aS,4R,6S,6aR)-6-(2-hydroxyethoxy)-2,2-dimethyltetrahydro- 4H-cyclopenta[d][1,3]dioxol-4-yl)-5-(propylthio)-3H-[1,2,3] triazolo[4,5-d]pyrimidin-7-ol |
1456538-51-4 |
C17H25N5O5S |
![Prasugrel Impurity 15](/) |
Prasugrel Impurity 15 |
|
|
![Pregabalin Impurity 18](/CAS/20210111/GIF/1621171-19-4.gif) |
Pregabalin Impurity 18 |
1621171-19-4 |
C9H15NO2 |
![Pregabalin Impurity 23](/) |
Pregabalin Impurity 23 |
|
|
![Butylphthalide impurity](/CAS/20200401/GIF/16692-58-3.gif) |
Butylphthalide impurity |
16692-58-3 |
C12H14O2 |
![ethyl 2,5-dihydroxybenzenesulfonate](/CAS/20200401/GIF/CB94671207.gif) |
ethyl 2,5-dihydroxybenzenesulfonate |
|
C8H10O5S |
![5-ALLYLIDENE-10,11-DIHYDRO-5H-DIBENZO[A,D]CYCLOHEPTENE](/CAS/GIF/24755-73-5.gif) |
5-ALLYLIDENE-10,11-DIHYDRO-5H-DIBENZO[A,D]CYCLOHEPTENE |
24755-73-5 |
C18H16 |
![Nintedanib Impurity 27](/) |
Nintedanib Impurity 27 |
|
|
![ethyl 2-(2-formyl-3-hydroxyphenyl)-4-methylthiazole-5- carboxylate](/CAS/20200401/GIF/CB94676626.gif) |
ethyl 2-(2-formyl-3-hydroxyphenyl)-4-methylthiazole-5- carboxylate |
|
C14H13NO4S |
![LUMAT-004](/CAS/20200515/GIF/313544-31-9.gif) |
LUMAT-004 |
313544-31-9 |
C16H17N3O3 |
![Varenicline Impurity 3](/CAS/20210111/GIF/1333145-89-3.gif) |
Varenicline Impurity 3 |
1333145-89-3 |
C14H15N3 |
![Amlodipine Impurity 22 (Z-Isomer)](/CAS/20200401/GIF/CB94744859.gif) |
Amlodipine Impurity 22 (Z-Isomer) |
|
C26H31ClN2O8S |
![Amlodipine Impurity 28](/CAS/20200401/GIF/79781-21-8.gif) |
Amlodipine Impurity 28 |
79781-21-8 |
C18H20ClNO5 |
![Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-[2-ethoxy-5-[(4-ethyl-4-oxido-1-piperazinyl)sulfonyl]phenyl]-5-methyl-7-propyl-](/CAS/20210111/GIF/448184-48-3.gif) |
Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-[2-ethoxy-5-[(4-ethyl-4-oxido-1-piperazinyl)sulfonyl]phenyl]-5-methyl-7-propyl- |
448184-48-3 |
C23H32N6O5S |
![Dolutegravir 4-Desfluoro Impurity](/CAS/20200611/GIF/1863916-87-3.gif) |
Dolutegravir 4-Desfluoro Impurity |
1863916-87-3 |
C20H20FN3O5 |
![Tetrabenazine Dehydro Impurity](/CAS/20210305/GIF/100322-43-8.gif) |
Tetrabenazine Dehydro Impurity |
100322-43-8 |
C19H25NO3 |
![Cefotiam Impurity 22](/CAS/20210111/GIF/1628441-07-5.gif) |
Cefotiam Impurity 22 |
1628441-07-5 |
C13H14N4O5S2 |
![Dezocine Impurity 2](/CAS/20210111/GIF/100667-17-2.gif) |
Dezocine Impurity 2 |
100667-17-2 |
C16H21NO |
![loteprednol Impurity 7](/CAS/20211123/GIF/82034-20-6.gif) |
loteprednol Impurity 7 |
82034-20-6 |
C24H33ClO7 |
![Sitagliptin Impurity 28](/CAS/20210111/GIF/898543-70-9.gif) |
Sitagliptin Impurity 28 |
898543-70-9 |
C32H25F12N9O2 |
![Vilanterol Impurity 3 Triphenylacetate](/CAS/20211123/GIF/503070-62-0.gif) |
Vilanterol Impurity 3 Triphenylacetate |
503070-62-0 |
C23H31Cl2NO5 |
![Empagliflozin Impurity 33](/) |
Empagliflozin Impurity 33 |
|
|
![Sugammadex Impurity 21](/CAS/20211123/GIF/2412952-93-1.gif) |
Sugammadex Impurity 21 |
2412952-93-1 |
C72H113NaO48S8 |
![4-((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzaldehyde trihydrochloride](/CAS/20200401/GIF/1254176-45-8.gif) |
4-((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzaldehyde trihydrochloride |
1254176-45-8 |
C18H30N4O |
![3'-Deoxyneamine](/CAS/20210111/GIF/34051-04-2.gif) |
3'-Deoxyneamine |
34051-04-2 |
C12H26N4O5 |
![Remifentanil Impurity 1 (RTF-02)](/CAS/20210111/GIF/938184-94-2.gif) |
Remifentanil Impurity 1 (RTF-02) |
938184-94-2 |
C16H21N3O2 |
![methyl (3aS,4R,6S,6aR)-4-((tert-butoxycarbonyl)amino)-3-(pentan-3-yl)-3a,5,6,6a-tetrahydro-4H-cyclopenta[d]isoxazole-6-carboxylate](/CAS/20200611/GIF/383910-25-6.gif) |
methyl (3aS,4R,6S,6aR)-4-((tert-butoxycarbonyl)amino)-3-(pentan-3-yl)-3a,5,6,6a-tetrahydro-4H-cyclopenta[d]isoxazole-6-carboxylate |
383910-25-6 |
C18H30N2O5 |
![sodium (((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy) methyl)oxidophosphoryl)-L-alaninate](/CAS/20200401/GIF/382140-24-1.gif) |
sodium (((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy) methyl)oxidophosphoryl)-L-alaninate |
382140-24-1 |
C12H19N6O5P |
![Zopiclone Impurity 13](/) |
Zopiclone Impurity 13 |
|
|
![1-Methyl-2,3-dihydroindol-2,3-dion](/CAS/GIF/2058-74-4.gif) |
1-Methyl-2,3-dihydroindol-2,3-dion |
2058-74-4 |
C9H7NO2 |
![1-bromo-3-(4-ethoxybenzyl)benzene](/CAS/20200401/GIF/898538-17-5.gif) |
1-bromo-3-(4-ethoxybenzyl)benzene |
898538-17-5 |
C15H15BrO |
![(2S,3R,4R,5S,6R)-2-(4-chloro-3-((4-ethoxyphenyl)(methoxy) methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol](/CAS/20200401/GIF/1318794-28-3.gif) |
(2S,3R,4R,5S,6R)-2-(4-chloro-3-((4-ethoxyphenyl)(methoxy) methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
1318794-28-3 |
C22H27ClO7 |
![Brivaracetam Impurity](/CAS/20210305/GIF/2432911-37-8.gif) |
Brivaracetam Impurity |
2432911-37-8 |
C11H22O3 |
![Cefminox Sodium impurity 5](/) |
Cefminox Sodium impurity 5 |
|
|
![Moxifloxacin Impurity 37](/CAS/20200611/GIF/1803729-19-2.gif) |
Moxifloxacin Impurity 37 |
1803729-19-2 |
C7H3ClF2O2 |
![Nimodipine Impurity 12](/CAS/20200611/GIF/39562-18-0.gif) |
Nimodipine Impurity 12 |
39562-18-0 |
C19H22N2O6 |
![Rosuvastatin Impurity 53](/) |
Rosuvastatin Impurity 53 |
|
|
![Sulbactam Impurity 8](/CAS/20210111/GIF/75527-88-7.gif) |
Sulbactam Impurity 8 |
75527-88-7 |
C8H10BrNO5S |
![Tenofovir Impurity 64](/CAS/20200611/GIF/1878175-76-8.gif) |
Tenofovir Impurity 64 |
1878175-76-8 |
C13H23N5O8P2 |
![Ticagrelor Impurity 65](/) |
Ticagrelor Impurity 65 |
|
|
![Ticagrelor Impurity 72](/CAS/20210111/GIF/1402150-11-1.gif) |
Ticagrelor Impurity 72 |
1402150-11-1 |
C24H28F2N6O5S |
![Topiroxostat Impurity 18](/) |
Topiroxostat Impurity 18 |
|
|
![Amifostine Impurity 5](/CAS/20210305/GIF/712255-27-1.gif) |
Amifostine Impurity 5 |
712255-27-1 |
C5H9BrN2 |
![Aztreonam Impurity 5](/CAS/20210111/GIF/2195336-17-3.gif) |
Aztreonam Impurity 5 |
2195336-17-3 |
C4H10N2O5S |
![Canagliflozin Impurity 35](/) |
Canagliflozin Impurity 35 |
|
|
![Cefazolin Impurity 7 (Cefazolin Trimethylsilyl Ester)](/CAS/20210111/GIF/1072000-00-0.gif) |
Cefazolin Impurity 7 (Cefazolin Trimethylsilyl Ester) |
1072000-00-0 |
C17H22N8O4S3Si |
![Dapagliflozin Impurity 25](/) |
Dapagliflozin Impurity 25 |
|
|
![Doripenem Impurity 1](/) |
Doripenem Impurity 1 |
|
|
![Erlotinib Impurity 54](/) |
Erlotinib Impurity 54 |
|
|
![Erlotinib Impurity 59](/) |
Erlotinib Impurity 59 |
|
|
![Etoposide Impurity 5](/) |
Etoposide Impurity 5 |
|
|
![Olaparib Impurity 26](/) |
Olaparib Impurity 26 |
|
|
![Oseltamivir Impurity 14](/CAS/20210305/GIF/2081110-44-1.gif) |
Oseltamivir Impurity 14 |
2081110-44-1 |
C16H28N2O4 |
![Rocuronium bromide Impurity 35](/) |
Rocuronium bromide Impurity 35 |
|
|
![AZD9291 Osimertinib Impurity 1](/) |
AZD9291 Osimertinib Impurity 1 |
|
|
![Dextrorotation lansoprazole Impurity I](/) |
Dextrorotation lansoprazole Impurity I |
|
|
![Ivabradine Impurity 31](/) |
Ivabradine Impurity 31 |
|
|
![isopropyl 2-(2-oxopyrrolidin-1-yl)acetate](/CAS/20210111/GIF/1249080-59-8.gif) |
isopropyl 2-(2-oxopyrrolidin-1-yl)acetate |
1249080-59-8 |
C9H15NO3 |
![Pitavastatin Impurity 71](/) |
Pitavastatin Impurity 71 |
|
|
![Rosuvastatin EP Impurity M Sodium Salt](/) |
Rosuvastatin EP Impurity M Sodium Salt |
|
|
![Furosemide impurity 8](/) |
Furosemide impurity 8 |
|
|
![Febuxostat Impurity 108](/) |
Febuxostat Impurity 108 |
|
|
![Flucloxacillin EP Impurity J](/) |
Flucloxacillin EP Impurity J |
|
|
![Phosphonic acid, P-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, mono[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethyl] ester](/CAS/20200611/GIF/1878175-77-9.gif) |
Phosphonic acid, P-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, mono[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethyl] ester |
1878175-77-9 |
C17H23N10O4P |
![Hexanoic acid, 3-formyl-, ethyl ester](/CAS/20200611/GIF/54374-02-6.gif) |
Hexanoic acid, 3-formyl-, ethyl ester |
54374-02-6 |
C9H16O3 |
![D-erythro-Hexonic acid, 2,4-dideoxy-3,5-O-(1-methylethylidene)-](/CAS/20200611/GIF/154877-92-6.gif) |
D-erythro-Hexonic acid, 2,4-dideoxy-3,5-O-(1-methylethylidene)- |
154877-92-6 |
C9H16O5 |
![INDEX NAME NOT YET ASSIGNED](/CAS/20211123/GIF/2463617-49-2.gif) |
INDEX NAME NOT YET ASSIGNED |
2463617-49-2 |
C51H56N16O4 |
![Benzoic acid, 4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]-](/CAS/20210111/GIF/906673-43-6.gif) |
Benzoic acid, 4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]- |
906673-43-6 |
C14H11BO5 |
![1H-Purine-2,6-dione, 8-(3-amino-1-piperidinyl)-7-(3-chloro-2-buten-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-](/CAS/20210111/GIF/2138805-26-0.gif) |
1H-Purine-2,6-dione, 8-(3-amino-1-piperidinyl)-7-(3-chloro-2-buten-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]- |
2138805-26-0 |
C25H29ClN8O2 |
![1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4-diiodo-](/CAS/20210111/GIF/1651211-78-7.gif) |
1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4-diiodo- |
1651211-78-7 |
C19H27I2N3O9 |
![(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxy-3-ethylbenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol](/) |
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxy-3-ethylbenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
|
|
![(E)-1-(4-(2-carboxyvinyl)benzyl)-1H-imidazole 3-oxide](/) |
(E)-1-(4-(2-carboxyvinyl)benzyl)-1H-imidazole 3-oxide |
|
|
![Vonoprazan Impurity B-2](/) |
Vonoprazan Impurity B-2 |
|
|
![2-(Cyanomethylthio)acetic acid](/CAS/GIF/55817-29-3.gif) |
2-(Cyanomethylthio)acetic acid |
55817-29-3 |
C4H5NO2S |
![Budesonide Impurity 31](/) |
Budesonide Impurity 31 |
|
|
![Budesonide Impurity 23](/) |
Budesonide Impurity 23 |
|
|
![Hexanoic acid, 3-(chloromethyl)-, (3R)-](/CAS/20210111/GIF/2101641-90-9.gif) |
Hexanoic acid, 3-(chloromethyl)-, (3R)- |
2101641-90-9 |
C7H13ClO2 |
![Bisoprolol Impurity](/CAS/20210305/GIF/2226263-68-7.gif) |
Bisoprolol Impurity |
2226263-68-7 |
C18H31NO4 |
![2(1H)-Quinolinone, 5-[(1R)-1,2-dihydroxyethyl]-8-(phenylmethoxy)-](/CAS/20210111/GIF/1261219-83-3.gif) |
2(1H)-Quinolinone, 5-[(1R)-1,2-dihydroxyethyl]-8-(phenylmethoxy)- |
1261219-83-3 |
C18H17NO4 |
![Tofacitinib Impurity](/CAS/20211123/GIF/2504210-41-5.gif) |
Tofacitinib Impurity |
2504210-41-5 |
C29H38N10O2 |